Induction Risk: Hyperstimulation, Unfavorable Cervix, and Failed Induction

Inducing labor means starting contractions with drugs, usually oxytocin (Pitocin) or a prostaglandin such as misoprostol. The most common problem is that the drug works too well. Tachysystole, defined as more than five contractions in ten minutes, can drop the baby's heart rate and cause fetal distress. That is the reason induced labor is tied to continuous monitoring and, often, to the bed. Pitocin sits on the ISMP High Alert list alongside insulin and chemotherapy for exactly this reason.

The second problem is a cervix that is not ready. In first-time mothers, observational data put the cesarean rate at 11.5 percent with spontaneous labor versus 23.7 percent with induction, and 31.5 percent when the Bishop score is under 5. An unfavorable cervix carries an adjusted odds ratio of about 2.32 for cesarean. A failed induction is a real outcome: hours of drugs and monitoring that end in surgery.

The honest caveat runs the other way too. The claim that induction doubles your cesarean risk compares induction to spontaneous labor, which is the wrong comparison, because the real choice is induction versus continuing to wait. The ARRIVE trial (NEJM, 2018) made that fairer comparison in 6,106 low-risk first-time mothers and found cesareans slightly lower with induction at 39 weeks, 18.6 versus 22.2 percent. Under trial conditions, a planned 39-week induction in a low-risk first pregnancy did not raise the surgery rate. The gap between that controlled setting and how broadly induction is now applied is where the risk lives.